Civic News
Events / Health

Get moving for a good cause with these two virtual 5Ks

Need motivation to get out and run or walk? These events will help spread Sickle Cell awareness and empower youth.

Dr. Nina Anderson of TOVA Community Health. (Courtesy photo)

The weather has finally cooled down, making the time right for a charity 5K.

Fittingly, there are two such events scheduled this weekend, but participants won’t be running/walking together at a set location. Keeping in line with COVID-19 precautions, Wilmington’s 8th James Faucett III Sickle Cell Awareness 5K, and Claymont’s C3 5K will both be virtual.

“Virtual” usually means inside or via Zoom. In the case of virtual 5K races, however, participants are encouraged to social-distance walk or run in their neighborhood or a nearby park for at least 20 minutes over the weekend on September 26-27 and share it on social media. (You could skip the walk/run and just donate, but who can’t use at least 20 minutes of movement outside right now?)

TOVA Community Health in Wilmington is the organizer of the James Faucett III Sickle Cell Awareness 5K, and proceeds will help the organization provide care and outreach to individuals with complex medical conditions like sickle cell anemia/trait. You can register with any size donation; each $20 donation gets a red “Sickle Cell Lives Matter” T-shirt to wear on your walk or run that can be picked up at its Greenhill Avenue site.

The Claymont Community Center is the organizer of the C3 Virtual 5K, and proceeds will support its Empowered Youth program, serving students in grades 5 through 8. Registration is $25 per person. C3 is still seeking promotional volunteers.

Engagement

Join the conversation!

Find news, events, jobs and people who share your interests on Technical.ly's open community Slack

Trending

How venture capital is changing, and why it matters

What company leaders need to know about the CTA and required reporting

Why the DOJ chose New Jersey for the Apple antitrust lawsuit

The Delaware Digital Equity plan has been approved. What's next?

Technically Media